文献速递产科母胎医学

比利时产前巨细胞病毒检测与管理现状调查

Current Practices in Antenatal CMV Testing and Management in Belgium.
PubMed 文献 · Prenat Diagn · 2026-10-08

结果显示,尽管比利时不建议普遍产前CMV筛查且检测不予报销,89.4%的受访者仍报告会申请产前CMV检测;胎儿医学专家中51.7%常规处方伐昔洛韦。终止妊娠可在无严重胎儿受累时发生,提示需高质量咨询和更新国家指南。

要点

  • 比利时虽不推荐普遍产前CMV筛查且检测不报销,89.4%受访者仍报告申请产前CMV检测。
  • 胎儿医学专家中51.7%常规处方伐昔洛韦,治疗接受度和依从性 perceived 良好。
  • 终止妊娠可在无严重胎儿受累时发生,需高质量咨询和更新国家指南。

核心结论

  • 尽管比利时不推荐普遍产前CMV筛查且检测不予报销,受访者中产前CMV检测仍被普遍报告。
  • 终止妊娠可能在无严重胎儿受累的情况下发生,凸显高质量咨询和更新国家指南的必要性。

研究设计与样本

  • 分析298份完整问卷的定量数据采用描述性统计,开放性问题回答采用主题分析。

主要发现

  • 89.4%的受访者报告申请产前CMV检测,尽管比利时不推荐产前CMV筛查且孕期CMV检测无常规报销。
  • 产前检测可能包括确定母体血清状态以及旨在检测原发性母体感染或血清转化的检测。
  • 检测目的包括胎儿影像学随访、卫生咨询和伐昔洛韦预防垂直传播,考虑终止妊娠较少被提及。
  • 终止妊娠被认为可在母体感染后各阶段发生,但主要在严重胎儿受累病例中。
  • 胎儿医学专家中51.7%常规处方伐昔洛韦,其他人非常规处方;治疗接受度和依从性 perceived 良好,成本是治疗接受的主要障碍,高药片负担是治疗依从的主要障碍。

临床怎么用

  • 临床医生应意识到产前CMV检测在比利时被广泛申请,但使用因成本障碍而异质。
  • 对CMV感染孕妇应提供高质量咨询,包括终止妊娠选项,即使无严重胎儿受累。
  • 胎儿医学专家中约半数常规处方伐昔洛韦,需关注治疗成本和药片负担对接受度和依从性的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe current practices regarding antenatal cytomegalovirus (CMV) testing, valaciclovir treatment and termination of pregnancy (TOP) in Belgium, where universal antenatal CMV screening is not recommended and testing during pregnancy is not reimbursed. METHOD: We conducted an online survey of practitioners involved in antenatal care or specialist management of CMV (obstetricians, midwives, general practitioners, fetal medicine specialists) between September and November 2024. Quantitative data from complete questionnaires were analyzed using descriptive statistics, and responses to open questions underwent thematic analysis. RESULTS: We analyzed 298 complete responses. Most respondents (89.4%) reported requesting antenatal CMV testing despite antenatal CMV screening not being recommended in Belgium and the absence of routine reimbursement for CMV testing during pregnancy. Antenatal testing may have included both determination of maternal serostatus and testing intended to detect primary maternal infection or seroconversion. Testing objectives included fetal imaging follow-up, hygiene counseling, and prevention of vertical transmission with valaciclovir, while considering TOP was less frequently cited. TOP was perceived as occurring at all stages after maternal infection, but predominantly in cases of severe fetal involvement. Among fetal medicine specialists, 51.7% prescribed valaciclovir routinely, while others prescribed it non-routinely. Treatment acceptance and adherence were perceived as good, with cost identified as the main barrier for treatment acceptance and high pill burden identified as the main barrier for treatment adherence. CONCLUSION: Antenatal CMV testing was commonly reported among respondents, despite heterogeneous use due to cost barriers. TOP may occur even in cases without severe fetal involvement, underscoring the need for high-quality counseling and updated national guidance.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Costa E, Jong CP, Verleye L, et al. Current Practices in Antenatal CMV Testing and Management in Belgium. Prenat Diagn. 2026. PMID: 42849456. doi:10.1002/pd.70272

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。